Immune 73: Big macs
Immune
00:00
The Potential Influence of Duplimumab on COVID-19 Severity
The chapter explores the question of whether the use of Duplimumab, an eczema injection containing IL-4 and IL-13 blockers, could lead to a more severe case of COVID-19. The hosts discuss the lack of studies on this specific drug and its effects on the virus, and mention the potential role of type two responses in modulating infections.
Transcript
Play full episode
